Maotang Zhou

Dr. Maotang Zhou is a branch chief in the Office of Pharmaceutical Manufacturing Assessment (OPMA), OPQ, CDER, FDA. He joined the FDA in 2008 and has amassed a wealth of experience in leading and performing quality and manufacturing assessments for both new and generic drug applications including those of complex APIs/dosage forms. Dr. Zhou significantly contributes to the development of guidances, policies, and Manuals for Policies and procedures (MaPPs) by serving on various working groups and technical committees at CDER. Prior to joining FDA, Dr. Zhou was a vice president (VP) at Chiral Quest where he oversaw the firm’s R&D organization in developing API commercial manufacturing processes. Dr. Zhou also worked as a senior scientist at Wyeth Pharmaceutical for three years and Bristol-Myers Squibb for eight years. Dr. Zhou received his bachelor’s degree from Sichuan University, his master’s degree from the Chinese Academy of Sciences, and his Ph.D. from the State University of New York at Albany.